Correlation Between Spire Global and Invex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spire Global and Invex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spire Global and Invex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spire Global and Invex Therapeutics, you can compare the effects of market volatilities on Spire Global and Invex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spire Global with a short position of Invex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spire Global and Invex Therapeutics.

Diversification Opportunities for Spire Global and Invex Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Spire and Invex is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Spire Global and Invex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invex Therapeutics and Spire Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spire Global are associated (or correlated) with Invex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invex Therapeutics has no effect on the direction of Spire Global i.e., Spire Global and Invex Therapeutics go up and down completely randomly.

Pair Corralation between Spire Global and Invex Therapeutics

Given the investment horizon of 90 days Spire Global is expected to generate 1.27 times more return on investment than Invex Therapeutics. However, Spire Global is 1.27 times more volatile than Invex Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Invex Therapeutics is currently generating about -0.27 per unit of risk. If you would invest  1,150  in Spire Global on September 12, 2024 and sell it today you would earn a total of  240.50  from holding Spire Global or generate 20.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Spire Global  vs.  Invex Therapeutics

 Performance 
       Timeline  
Spire Global 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Spire Global are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating forward indicators, Spire Global reported solid returns over the last few months and may actually be approaching a breakup point.
Invex Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Invex Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, Invex Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Spire Global and Invex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spire Global and Invex Therapeutics

The main advantage of trading using opposite Spire Global and Invex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spire Global position performs unexpectedly, Invex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invex Therapeutics will offset losses from the drop in Invex Therapeutics' long position.
The idea behind Spire Global and Invex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Content Syndication
Quickly integrate customizable finance content to your own investment portal